Selected research
Industry Growth & Trends
Global RNA Synthesis Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global RNA Synthesis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for RNA Synthesis is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for RNA Synthesis is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for RNA Synthesis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the RNA Synthesis market include GenScript, Hokkaido System Science, Bio-Synthesis, IDT, Thermo Fisher Scientific, Genewiz, Gene Universal, TriLink BioTechnologies and GE Healthcare Dharmacon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global RNA Synthesis market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The RNA Synthesis market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global RNA Synthesis market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to RNA Synthesis.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global RNA Synthesis market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
RNA Synthesis Market by Company
GenScript
Hokkaido System Science
Bio-Synthesis
IDT
Thermo Fisher Scientific
Genewiz
Gene Universal
TriLink BioTechnologies
GE Healthcare Dharmacon
ChemGenes
Creative Biolabs
Glen Research
VeliterBio
Creative Biogene
Merck
Eurofins Scientific
RNA Synthesis Segment by Type
mRNA Synthesis
tRNA Synthesis
rRNA Synthesis
siRNA Synthesis
RNA Synthesis Segment by Application
Biomedical Science
Pharmaceutical
Others
RNA Synthesis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RNA Synthesis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of RNA Synthesis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RNA Synthesis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of RNA Synthesis companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- mRNA Synthesis
- tRNA Synthesis
- rRNA Synthesis
- siRNA Synthesis
Applications
- Biomedical Science
- Pharmaceutical
- Others
Companies covered
- GenScript
- Hokkaido System Science
- Bio-Synthesis
- IDT
- Thermo Fisher Scientific
- Genewiz
- Gene Universal
- TriLink BioTechnologies
- GE Healthcare Dharmacon
- ChemGenes
- Creative Biolabs
- Glen Research
- VeliterBio
- Creative Biogene
- Merck
- Eurofins Scientific
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global RNA Synthesis Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global RNA Synthesis Market Size by Region (2021-2032)
- 1.4.1 Global RNA Synthesis Market Size by Region (2021-2026)
- 1.4.2 Global RNA Synthesis Market Size by Region (2027-2032)
- 1.5 Key Regions RNA Synthesis Market Size (2021-2032)
- 1.5.1 North America RNA Synthesis Market Size Growth Rate (2021-2032)
- 1.5.2 Europe RNA Synthesis Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific RNA Synthesis Market Size Growth Rate (2021-2032)
- 1.5.4 South America RNA Synthesis Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa RNA Synthesis Market Size Growth Rate (2021-2032)
2 RNA Synthesis Market by Type
- 2.1 Type Introduction
- 2.1.1 mRNA Synthesis
- 2.1.2 tRNA Synthesis
- 2.1.3 rRNA Synthesis
- 2.1.4 siRNA Synthesis
- 2.2 Global RNA Synthesis Market Size by Type
- 2.2.1 Global RNA Synthesis Market Size Overview by Type (2021-2032)
- 2.2.2 Global RNA Synthesis Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global RNA Synthesis Market Size Forecasted by Type (2027-2032)
- 2.3 Global RNA Synthesis Market Size by Regions
- 2.3.1 North America RNA Synthesis Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe RNA Synthesis Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific RNA Synthesis Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America RNA Synthesis Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa RNA Synthesis Market Size Breakdown by Type (2021-2026)
3 RNA Synthesis Market by Application
- 3.1 Type Introduction
- 3.1.1 Biomedical Science
- 3.1.2 Pharmaceutical
- 3.1.3 Others
- 3.2 Global RNA Synthesis Market Size by Application
- 3.2.1 Global RNA Synthesis Market Size Overview by Application (2021-2032)
- 3.2.2 Global RNA Synthesis Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global RNA Synthesis Market Size Forecasted by Application (2027-2032)
- 3.3 Global RNA Synthesis Market Size by Regions
- 3.3.1 North America RNA Synthesis Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe RNA Synthesis Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific RNA Synthesis Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America RNA Synthesis Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa RNA Synthesis Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 RNA Synthesis Industry Trends
- 4.2 RNA Synthesis Industry Drivers
- 4.3 RNA Synthesis Industry Opportunities and Challenges
- 4.4 RNA Synthesis Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by RNA Synthesis Revenue (2021-2026)
- 5.2 Global RNA Synthesis Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global RNA Synthesis Key Company Headquarters & Area Served
- 5.4 Global RNA Synthesis Company, Product Type & Application
- 5.5 Global RNA Synthesis Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global RNA Synthesis Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 RNA Synthesis Players Market Share by Revenue in 2025
- 5.6.3 2025 RNA Synthesis Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 GenScript
- 6.1.1 GenScript Company Information
- 6.1.2 GenScript Business Overview
- 6.1.3 GenScript RNA Synthesis Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 GenScript RNA Synthesis Product Portfolio
- 6.1.5 GenScript Recent Developments
- 6.2 Hokkaido System Science
- 6.2.1 Hokkaido System Science Company Information
- 6.2.2 Hokkaido System Science Business Overview
- 6.2.3 Hokkaido System Science RNA Synthesis Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Hokkaido System Science RNA Synthesis Product Portfolio
- 6.2.5 Hokkaido System Science Recent Developments
- 6.3 Bio-Synthesis
- 6.3.1 Bio-Synthesis Company Information
- 6.3.2 Bio-Synthesis Business Overview
- 6.3.3 Bio-Synthesis RNA Synthesis Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Bio-Synthesis RNA Synthesis Product Portfolio
- 6.3.5 Bio-Synthesis Recent Developments
- 6.4 IDT
- 6.4.1 IDT Company Information
- 6.4.2 IDT Business Overview
- 6.4.3 IDT RNA Synthesis Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 IDT RNA Synthesis Product Portfolio
- 6.4.5 IDT Recent Developments
- 6.5 Thermo Fisher Scientific
- 6.5.1 Thermo Fisher Scientific Company Information
- 6.5.2 Thermo Fisher Scientific Business Overview
- 6.5.3 Thermo Fisher Scientific RNA Synthesis Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Thermo Fisher Scientific RNA Synthesis Product Portfolio
- 6.5.5 Thermo Fisher Scientific Recent Developments
- 6.6 Genewiz
- 6.6.1 Genewiz Company Information
- 6.6.2 Genewiz Business Overview
- 6.6.3 Genewiz RNA Synthesis Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Genewiz RNA Synthesis Product Portfolio
- 6.6.5 Genewiz Recent Developments
- 6.7 Gene Universal
- 6.7.1 Gene Universal Company Information
- 6.7.2 Gene Universal Business Overview
- 6.7.3 Gene Universal RNA Synthesis Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Gene Universal RNA Synthesis Product Portfolio
- 6.7.5 Gene Universal Recent Developments
- 6.8 TriLink BioTechnologies
- 6.8.1 TriLink BioTechnologies Company Information
- 6.8.2 TriLink BioTechnologies Business Overview
- 6.8.3 TriLink BioTechnologies RNA Synthesis Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 TriLink BioTechnologies RNA Synthesis Product Portfolio
- 6.8.5 TriLink BioTechnologies Recent Developments
- 6.9 GE Healthcare Dharmacon
- 6.9.1 GE Healthcare Dharmacon Company Information
- 6.9.2 GE Healthcare Dharmacon Business Overview
- 6.9.3 GE Healthcare Dharmacon RNA Synthesis Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 GE Healthcare Dharmacon RNA Synthesis Product Portfolio
- 6.9.5 GE Healthcare Dharmacon Recent Developments
- 6.10 ChemGenes
- 6.10.1 ChemGenes Company Information
- 6.10.2 ChemGenes Business Overview
- 6.10.3 ChemGenes RNA Synthesis Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 ChemGenes RNA Synthesis Product Portfolio
- 6.10.5 ChemGenes Recent Developments
- 6.11 Creative Biolabs
- 6.11.1 Creative Biolabs Company Information
- 6.11.2 Creative Biolabs Business Overview
- 6.11.3 Creative Biolabs RNA Synthesis Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Creative Biolabs RNA Synthesis Product Portfolio
- 6.11.5 Creative Biolabs Recent Developments
- 6.12 Glen Research
- 6.12.1 Glen Research Company Information
- 6.12.2 Glen Research Business Overview
- 6.12.3 Glen Research RNA Synthesis Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Glen Research RNA Synthesis Product Portfolio
- 6.12.5 Glen Research Recent Developments
- 6.13 VeliterBio
- 6.13.1 VeliterBio Company Information
- 6.13.2 VeliterBio Business Overview
- 6.13.3 VeliterBio RNA Synthesis Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 VeliterBio RNA Synthesis Product Portfolio
- 6.13.5 VeliterBio Recent Developments
- 6.14 Creative Biogene
- 6.14.1 Creative Biogene Company Information
- 6.14.2 Creative Biogene Business Overview
- 6.14.3 Creative Biogene RNA Synthesis Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Creative Biogene RNA Synthesis Product Portfolio
- 6.14.5 Creative Biogene Recent Developments
- 6.15 Merck
- 6.15.1 Merck Company Information
- 6.15.2 Merck Business Overview
- 6.15.3 Merck RNA Synthesis Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Merck RNA Synthesis Product Portfolio
- 6.15.5 Merck Recent Developments
- 6.16 Eurofins Scientific
- 6.16.1 Eurofins Scientific Company Information
- 6.16.2 Eurofins Scientific Business Overview
- 6.16.3 Eurofins Scientific RNA Synthesis Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Eurofins Scientific RNA Synthesis Product Portfolio
- 6.16.5 Eurofins Scientific Recent Developments
7 North America
- 7.1 North America RNA Synthesis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America RNA Synthesis Market Size by Country (2021-2026)
- 7.3 North America RNA Synthesis Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe RNA Synthesis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe RNA Synthesis Market Size by Country (2021-2026)
- 8.3 Europe RNA Synthesis Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific RNA Synthesis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific RNA Synthesis Market Size by Country (2021-2026)
- 9.3 Asia-Pacific RNA Synthesis Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America RNA Synthesis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America RNA Synthesis Market Size by Country (2021-2026)
- 10.3 South America RNA Synthesis Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa RNA Synthesis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa RNA Synthesis Market Size by Country (2021-2026)
- 11.3 Middle East & Africa RNA Synthesis Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst